![Helen Phillips](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Phillips
Corporate Officer/Principal chez
AMRYT PHARMA PLC
Profil
Helen Phillips is currently the Head of Medical Affairs at Amryt Pharma Plc.
Prior to this, she held the position of Medical Director-EMEA at Aegerion Pharmaceuticals, Inc. and was also the Head of Medical Affairs at Amryt Pharma Holdings Ltd. She completed her undergraduate degree at the University of Bristol.
Postes actifs de Helen Phillips
| Sociétés | Poste | Début |
|---|---|---|
| AMRYT PHARMA PLC | Corporate Officer/Principal | - |
Anciens postes connus de Helen Phillips
| Sociétés | Poste | Fin |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Corporate Officer/Principal | - |
Formation de Helen Phillips
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
